Phosphocreatine preconditioning attenuates apoptosis in ischemia-reperfusion injury of rat brain

25Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Phosphocreatine (PCr) is an endogenous compound containing high-energy phosphate bonds. It has been confirmed that PCr is effective in preventing and treating cardiac and renal ischemia-reperfusion injury. In this study, rat cerebral ischemia-reperfusion injury models were constructed. Apoptotic cells in the cortex region were measured by TUNEL method. Malondialdehyde (MDA) content was detected by chromatometry, and calmodulin (CaM) activity was detected by ELISA. Compared with sham-operated group (sham group), TUNEL-positive cells, MDA, and level of CaM activity increased in ischemia-reperfusion group (I/R group) and PCr preconditioning group (PCr group); compared with I/R group, TUNEL-positive cells, MDA content, and level of CaM activity decreased in PCr group. This study indicated that PCr can decrease the morphological damage and the neuron apoptosis of the ischemia-reperfusion injury brain through attenuating abnormalities of calcium balance and production of oxygen free radicals. © 2011 Ling-Hua Tang et al.

Cite

CITATION STYLE

APA

Xia, Z. Y., Tang, L. H., Zhao, B., Wei, X. D., Luo, T., & Meng, Q. T. (2011). Phosphocreatine preconditioning attenuates apoptosis in ischemia-reperfusion injury of rat brain. Journal of Biomedicine and Biotechnology, 2011. https://doi.org/10.1155/2011/107091

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free